COVID-19 Now and Beyond: Where Do We Go from Here?

Published: December 3, 2023
multiple colorful lines merging into one arrow pointing up

The federal COVID-19 public health emergency (PHE) declaration expired May 11, 2023, but COVID-19 continues to be top of mind for the healthcare community — including the pharmacists who have been integral to the fight against COVID-19.

Join us Tuesday, Dec. 5, from 11:30 a.m. to 1 p.m. PT, for the Midday Symposium COVID-19 Now and Beyond: Where Do We Go From Here?, held in room 157, 100 Level, Anaheim Convention Center North. Earn 1.5 hours of CE credit.

The symposium will update attendees on the pharmacist’s role in COVID-19 prevention and treatment strategies, including the potential implications of the PHE expiration on coverage and access to vaccines, therapies, and tests. Our expert faculty will also summarize prevention and management strategies for COVID-19 in special patient populations. The activity will conclude with a review of new and emerging therapies for the prevention and treatment of COVID-19.

The Midday Symposium will also be broadcast as a live webinar for CE credit. If you have colleagues at home who are interested in this topic, encourage them to register for the webinar.

This activity is provided by ASHP and supported by educational grant from AstraZeneca.

Posted December 3, 2023

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information